Produktinformation
- (3aR,5R,11bR)-3,3a,5,11b-Tetrahydro-7-hydroxy-5-propyl-2H-furo[3,2-b]naphtho[2,3-d]pyran-2,6,11-trione
- (+)-Frenolicin B
- 2H-Furo[3,2-b]naphtho[2,3-d]pyran-2,6,11-trione, 3,3a,5,11b-tetrahydro-7-hydroxy-5-propyl-, (3aR,5R,11bR)-
- 2H-Furo[3,2-b]naphtho[2,3-d]pyran-2,6,11-trione, 3,3a,5,11b-tetrahydro-7-hydroxy-5-propyl-, [3aR-(3aα,5α,11bα)]-
Frenolicin B is a potent inhibitor of elastin and has been shown to induce apoptosis in human cancer cells. This protein kinase inhibitor has demonstrated significant anti-tumor activity in Chinese hamster ovary cells, as well as in various other tumor cell lines. Frenolicin B analogs have been developed as potential anticancer agents that target specific kinases involved in cancer cell growth and proliferation. Its unique ability to inhibit elastin degradation makes it a promising candidate for the treatment of diseases such as emphysema and aneurysm. Additionally, Frenolicin B has been detected in urine samples from humans, indicating its potential use as a diagnostic marker for certain diseases.
Chemische Eigenschaften
Technische Anfrage zu: 3D-XF183224 Frenolicin B
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.
